schizophrenia Archives
Insights for neuroscience drug discovery
Jul. 17, 2012—When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.
Perfect timing for sensory processing
May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
Minds wide open: Neuroscience at Vanderbilt
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Memory intact in early psychosis
Feb. 16, 2012—Brain deficits are not present in the early stages of schizophrenia, suggesting it may be possible to delay or prevent the development of brain abnormalities.
Tool finds connections in genome data
Feb. 8, 2012—A new analytical tool points to genes that act together to increase disease risk.
Information flow reduced in psychosis
Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.
Researchers strive to refill drug discovery ‘pipeline’
Oct. 3, 2011—Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism.
Connecting the dots in schizophrenia
Jul. 29, 2011—Abnormalities of the hippocampus, a seahorse-shaped brain region involved in learning and memory, may play a role in the psychotic symptoms and cognitive deficits of schizophrenia.
Neuroscience drug discovery center opens at Vanderbilt
Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.
